NASDAQ · MDXH
MDxHealth SA financials
$0.5200−5.11%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Dec 31 | Q4 '24 Dec 31 | Q4 '23 Dec 31 | Q4 '22 Dec 31 | Q4 '21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Gross margin | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | — | — | — | — | — |
| Net margin | — | — | — | — | — |
| Diluted EPS | — | — | — | — | — |
| EBITDA | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating cash flow | — | — | — | — | — |
| Free cash flow | — | — | — | — | — |
| Diluted shares | 50.0M | 32.9M | 25.9M | 15.9M | 12.2M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $29.0M | $46.8M | $22.4M | $15.5M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $106.8M | $77.7M | $36.2M | $35.5M |
| Total assets | $148.0M | $157.3M | $129.1M | $119.1M |
| Total liabilities | $160.0M | $142.5M | $121.9M | $109.8M |
| Shareholders' equity | -$12.1M | $14.8M | $7.2M | $9.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology